Clinical Trial Update: Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Doses of KQ-791 in Diabetes Mellitus [Phase 1]

View source ↗

Summary

Phase 1 trial update of KQ-791 in Type 2 diabetes assessing safety, tolerability, PK and PD across multiple ascending doses. Completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Type 2 Diabetes Mellitus

Drugs mentioned

• KQ-791

Snippet

Sponsor: Kaneq Bioscience Limited | Conditions: Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED | Results posted: 2019-10-30